Aprogen Medicines Inc. (KRX:007460)
South Korea
· Delayed Price · Currency is KRW 331.00
+14.00 (4.42%)
Mar 10, 2026, 11:00 AM KST
Aprogen Medicines Revenue
Aprogen Medicines had revenue of 35.55B KRW in the quarter ending September 30, 2025, a decrease of -3.37%. This brings the company's revenue in the last twelve months to 126.09B, down -14.72% year-over-year. In the year 2024, Aprogen Medicines had annual revenue of 150.11B, down -0.31%.
Revenue (ttm)
126.09B
Revenue Growth
-14.72%
P/S Ratio
0.78
Revenue / Employee
492.55M
Employees
256
Market Cap
97.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 150.11B | -464.40M | -0.31% |
| Dec 31, 2023 | 150.58B | 72.23B | 92.19% |
| Dec 31, 2022 | 78.35B | 52.05B | 197.95% |
| Dec 31, 2021 | 26.30B | -100.85B | -79.32% |
| Dec 31, 2020 | 127.14B | 48.89B | 62.48% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HLB GLOBAL | 103.52B |
| Singsong Holdings | 190.20B |
| Gridwiz | 121.79B |
| Woongjin | 1,092.76B |
| JLK, Inc. | 3.26B |
| HS HYOSUNG | 1,820.78B |
| Ocean In W | 7.52B |
| KPX Holdings | 1,204.40B |